You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

paclitaxel-containing chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Persistent, Recurrent, or Metastatic Cervical Cancer Trial in Shanghai (GLS-010, Placebo, paclitaxel)

Not yet recruiting
  • Persistent, Recurrent, or Metastatic Cervical Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Hospital
Apr 4, 2023

HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811, Ramucirumab / Paclitaxel/

Not yet recruiting
  • HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
  • SHR-A1811
  • Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan
  • (no location specified)
Nov 6, 2023

NSCLC Trial (QL1706 injection, Vinorelbine Tartrate, Paclitaxel)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • QL1706 injection
  • +6 more
  • (no location specified)
Aug 3, 2022

Cervical Cancer Trial in Guangzhou (SHR-1701 + paclitaxel + cisplatin/carboplatin + BP102, SHR-1701 + paclitaxel +

Recruiting
  • Cervical Cancer
  • SHR-1701 + paclitaxel + cisplatin/carboplatin + BP102
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 13, 2022

Cervical Cancer Trial in Hangzhou, Hefei, Shanghai (AK104, paclitaxel, carboplatin)

Recruiting
  • Cervical Cancer
  • AK104
  • +5 more
  • Hangzhou, China
  • +4 more
Apr 26, 2022

Adenocarcinoma of Pancreas Trial in Scottsdale (Hand Therapy Until CIPN)

Completed
  • Adenocarcinoma of Pancreas
  • Hand Therapy Until CIPN
  • Scottsdale, Arizona
    HonorHealth Research Institute
May 10, 2022

Metastatic NSCLC, Recurrent NSCLC, Advanced Non-Small Cell Squamous Lung Cancer Trial in Nanjing (Sintilimab + Anlotinib +

Recruiting
  • Metastatic NSCLC
  • +2 more
  • Sintilimab + Anlotinib + Pemetrexed + Cisplatin or Carboplatin
  • Sintilimab + Anlotinib + Albumin Paclitaxel + Carboplatin
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Aug 10, 2021

Cervical Esophagus Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Esophageal

Recruiting
  • Cervical Esophagus Adenocarcinoma
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Untreated Advanced NSCLC Trial in Fuzhou (Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and

Recruiting
  • Untreated Advanced Non-small Cell Lung Cancer
  • Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and platinum-containing two-drug chemotherapy
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Nov 13, 2023

Pancreatic Cancer Trial (TTX-030, nab-paclitaxel and gemcitabine, TTX-030, budigalimab, nab-paclitaxel and gemcitabine,

Not yet recruiting
  • Pancreatic Cancer
  • TTX-030, nab-paclitaxel and gemcitabine
  • +2 more
  • (no location specified)
Nov 3, 2023

Metastatic Pancreatic Adenocarcinoma Trial in Shanghai (Ascorbate, Nab paclitaxel, Gemcitabine)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Shanghai, Shanghai, China
    Shanghai Cancer Center
Aug 29, 2023

Early-stage Breast Cancer Trial in Ottawa (Granulocyte Colony-Stimulating Factor (G-CSF), Omission of Granulocyte

Not yet recruiting
  • Early-stage Breast Cancer
  • Granulocyte Colony-Stimulating Factor (G-CSF)
  • Omission of Granulocyte Colony-Stimulating Factor (G-CSF)
  • Ottawa, Ontario, Canada
    The Ottawa Hospital Cancer Centre
Feb 22, 2023

Endometrial Carcinoma Trial in Sohag (Paclitaxel/epirubcin/carboplatin, Paclitaxel/carboplatin)

Not yet recruiting
  • Endometrial Carcinoma
  • Sohag, Egypt
    Sohag university Hospital
Oct 25, 2023

Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) Trial in Tianjin (Serplulimab+Paclitaxel+Apatinib,

Recruiting
  • Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jul 5, 2023

TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • (no location specified)
May 8, 2023

Pancreatic Cancer Stage IV, Chemo-induced Nausea and Vomiting Trial (Thalidomide, Nab paclitaxel, Gemcitabine)

Not yet recruiting
  • Pancreatic Cancer Stage IV
  • Chemotherapy-induced Nausea and Vomiting
  • (no location specified)
Aug 24, 2023

Gastric or Esophagogastric Junction Adenocarcinoma Trial (nimotuzumab plus paclitaxel, plus paclitaxel)

Not yet recruiting
  • Gastric or Esophagogastric Junction Adenocarcinoma
  • nimotuzumab plus paclitaxel
  • placebo plus paclitaxel
  • (no location specified)
Aug 3, 2023

Paclitaxel-induced Polyneuropathy in Breast Cancer: Early

Not yet recruiting
  • Breast Neoplasms
  • +7 more
  • Garmin smartwatch
  • +2 more
  • Solna, Stockholm, Sweden
    Karolinska University Hospital
Sep 18, 2023

Albumin Binding Paclitaxel Compared With Common Paclitaxel in

Recruiting
  • Breast Cancer
  • Jinan, Shandong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Nov 24, 2022

Breast Carcinoma Trial in Houston (biological, drug, other)

Not yet recruiting
  • Breast Carcinoma
  • eftilagimod alpha
  • +2 more
  • Houston, Texas
    Oncology Consultants
Feb 17, 2023

Advanced Non-squamous Non-small-cell Lung Cancer, Recurrent Non-Squamous NSCLC, Metastatic Non-squamous Non Small Cell Lung

Not yet recruiting
  • Advanced Non-squamous Non-small-cell Lung Cancer
  • +2 more
  • Beijing, Beijing, China
    Peking University First Hospital Ethics Committee
Sep 10, 2023

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023

Chemo-induced Peripheral Neuropathy Trial (Curcumin, Paclitaxel)

Not yet recruiting
  • Chemotherapy-induced Peripheral Neuropathy
  • (no location specified)
Jul 21, 2023

Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)

Not yet recruiting
  • Esophageal Carcinoma
  • Neoadjuvant Therapy
  • (no location specified)
Aug 16, 2023

Esophageal Squamous Cell Carcinoma Trial in Nanjing (Carrelizumab, Paclitaxel injection, Cisplatin)

Enrolling by invitation
  • Esophageal Squamous Cell Carcinoma
  • Nanjing, China
    The First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023